Home
>
National Drug Code (NDC)
>
levetiracetam extended-release
levetiracetam extended-release - 60505-3517-5 - (levetiracetam)
Drug Information of levetiracetam extended-release
| Product NDC: | 60505-3517 |
| Proprietary Name: | levetiracetam extended-release |
| Non Proprietary Name: | levetiracetam |
| Active Ingredient(s): | 750 mg/1 & nbsp; levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of levetiracetam extended-release
| Product NDC: | 60505-3517 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091261 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110912 |
Package Information of levetiracetam extended-release
| Package NDC: | 60505-3517-5 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3517-5) |
NDC Information of levetiracetam extended-release
| NDC Code | 60505-3517-5 |
| Proprietary Name | levetiracetam extended-release |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3517-5) |
| Product NDC | 60505-3517 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levetiracetam |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110912 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | LEVETIRACETAM |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
